Sign In   |   Register
Menu

EAS President's review of 2018

Dear friends,

As the year draws to a close, we take time to reflect on the progress we have made in the Society’s activities during 2018, and look forward to the year ahead. Read the review here.

2019 promises to be an exciting year. Among many activities, we are looking forward to: the planned publication of new ESC-EAS guidelines in management of dyslipidaemia; there are several publications from the EAS Consensus Panel in the pipeline, and we will see launch of our new Open Access Journal “Atherosclerosis X”; our Congress in Maastricht EAS 2019 has already received a record number of abstracts, and has a programme filled with the field’s most highly regarded speakers; further Advanced Courses and activities aimed to support young scientists are planned, as is a new update to the “Certificate of Excellence in Lipidology Programme” on the EAS Academy; and the FHSC registry anticipates reaching a total of 40,000 patient records.

All EAS activities and initiatives are conceived, planned and carried out by dedicated and driven individuals, who, devote much time, energy and enthusiasm to the life of the Society. So much work is done by so many behind the scenes, in order that EAS can run the publication and educational activities that fulfil our aim - to advance knowledge in the field of atherosclerosis. On behalf of the Executive Committee, I take this opportunity to acknowledge and thank most sincerely every contribution, large or small.

We wish you health and happiness in the holiday season, and scientific success in 2019!

Lale Tokgozoglu MD FACC FESC
President, European Atherosclerosis Society
Professor of Cardiology
Hacettepe University
Ankara-Turkey

 

EAS 2019 Congress Maastricht, The Netherlands, May 26-29

The European Atherosclerosis Society (EAS) and the Dutch Atherosclerosis Society invite you to the Netherlands, to the charming and historic city of Maastricht and the 87th EAS Congress.

During the meeting we will explore the latest developments in research into the causes of atherosclerosis and related vascular disease, and how these may affect the clinical guidelines for diagnosis and treatment. Clinicians and basic researchers studying atherosclerosis and related vascular disease are welcome to submit an abstract, to present their findings to the international scientific community at EAS 2019.

To EAS 2019 and the Preliminary programme >>

See the very best of EAS 2018 - presentations and slides available on EAS ACADEMY

We know there are many clinicians and researchers who would like to attend EAS Congress, but cannot be there. If that’s you – there’s still a way to hear and see the very best of EAS 2018. Visit the EAS Academy to view webcast presentations and slides from plenary, selected workshop and keynote sessions.

Webcasts, presentations from EAS 2018 on EAS Academy>>

Read the Commentary - Highlights from the EAS 2018 Congress >>

Read the onsite reports and view video interviews from the Congress >>

2018 EAS FHSC publication - a survey of FH care in over 60 countries worldwide

FHSC’s new publication “Overview of the current status of Familial Hypercholesterolaemia care in over 60 countries - the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)” was accepted for publication on Atherosclerosis at the beginning of September and is now published, full text available for free.

More info, full text and commentary >>

Member sign in



Access the Society journal



Log in to access Atherosclerosis >>

Calendar more

03/12/2018 » 04/02/2019
Open for nominations: Young Investigator Award for Outstanding publications 2018

02/05/2019 » 05/05/2019
LIP 2019

EAS Academy
EAS Journal
Become an EAS Member
Guidelines
Membership Software Powered by YourMembership  ::  Legal